BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16216466)

  • 1. The placenta growth factor in skin angiogenesis.
    Odorisio T; Cianfarani F; Failla CM; Zambruno G
    J Dermatol Sci; 2006 Jan; 41(1):11-9. PubMed ID: 16216466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of placental growth factor.
    De Falco S; Gigante B; Persico MG
    Trends Cardiovasc Med; 2002 Aug; 12(6):241-6. PubMed ID: 12242046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis.
    Schomber T; Kopfstein L; Djonov V; Albrecht I; Baeriswyl V; Strittmatter K; Christofori G
    Cancer Res; 2007 Nov; 67(22):10840-8. PubMed ID: 18006829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
    Carmeliet P; Moons L; Luttun A; Vincenti V; Compernolle V; De Mol M; Wu Y; Bono F; Devy L; Beck H; Scholz D; Acker T; DiPalma T; Dewerchin M; Noel A; Stalmans I; Barra A; Blacher S; VandenDriessche T; Ponten A; Eriksson U; Plate KH; Foidart JM; Schaper W; Charnock-Jones DS; Hicklin DJ; Herbert JM; Collen D; Persico MG
    Nat Med; 2001 May; 7(5):575-83. PubMed ID: 11329059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.
    Roy H; Bhardwaj S; Babu M; Jauhiainen S; Herzig KH; Bellu AR; Haisma HJ; Carmeliet P; Alitalo K; Ylä-Herttuala S
    Hum Gene Ther; 2005 Dec; 16(12):1422-8. PubMed ID: 16390273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.
    Luttun A; Tjwa M; Moons L; Wu Y; Angelillo-Scherrer A; Liao F; Nagy JA; Hooper A; Priller J; De Klerck B; Compernolle V; Daci E; Bohlen P; Dewerchin M; Herbert JM; Fava R; Matthys P; Carmeliet G; Collen D; Dvorak HF; Hicklin DJ; Carmeliet P
    Nat Med; 2002 Aug; 8(8):831-40. PubMed ID: 12091877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed.
    Cianfarani F; Tommasi R; Failla CM; Viviano MT; Annessi G; Papi M; Zambruno G; Odorisio T
    Br J Dermatol; 2006 Jan; 154(1):34-41. PubMed ID: 16403091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential.
    Cianfarani F; Zambruno G; Brogelli L; Sera F; Lacal PM; Pesce M; Capogrossi MC; Failla CM; Napolitano M; Odorisio T
    Am J Pathol; 2006 Oct; 169(4):1167-82. PubMed ID: 17003476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis.
    Nagy JA; Dvorak AM; Dvorak HF
    Trends Cardiovasc Med; 2003 Jul; 13(5):169-75. PubMed ID: 12837578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.
    Eriksson A; Cao R; Pawliuk R; Berg SM; Tsang M; Zhou D; Fleet C; Tritsaris K; Dissing S; Leboulch P; Cao Y
    Cancer Cell; 2002 Feb; 1(1):99-108. PubMed ID: 12086892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
    Taylor AP; Rodriguez M; Adams K; Goldenberg DM; Blumenthal RD
    Int J Cancer; 2003 Jun; 105(2):158-64. PubMed ID: 12673673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta growth factor is not required for exercise-induced angiogenesis.
    Gigante B; Tarsitano M; Cimini V; De Falco S; Persico MG
    Angiogenesis; 2004; 7(3):277-84. PubMed ID: 15609082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical role of placental growth factor in the induction of inflammation and edema formation.
    Oura H; Bertoncini J; Velasco P; Brown LF; Carmeliet P; Detmar M
    Blood; 2003 Jan; 101(2):560-7. PubMed ID: 12393422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.
    Larcher F; Franco M; Bolontrade M; Rodriguez-Puebla M; Casanova L; Navarro M; Yancopoulos G; Jorcano JL; Conti CJ
    Mol Carcinog; 2003 Jun; 37(2):83-90. PubMed ID: 12766907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability.
    Odorisio T; Schietroma C; Zaccaria ML; Cianfarani F; Tiveron C; Tatangelo L; Failla CM; Zambruno G
    J Cell Sci; 2002 Jun; 115(Pt 12):2559-67. PubMed ID: 12045226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
    Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
    Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis.
    Fujii T; Yonemitsu Y; Onimaru M; Inoue M; Hasegawa M; Kuwano H; Sueishi K
    Atherosclerosis; 2008 Sep; 200(1):51-7. PubMed ID: 18258238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery of the placental growth factor and its role in angiogenesis: a historical review.
    Ribatti D
    Angiogenesis; 2008; 11(3):215-21. PubMed ID: 18568405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric VEGF-ENZ7/PlGF specifically binding to VEGFR-2 accelerates skin wound healing via enhancement of neovascularization.
    Zheng Y; Watanabe M; Kuraishi T; Hattori S; Kai C; Shibuya M
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):503-11. PubMed ID: 17194893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders.
    Luttun A; Tjwa M; Carmeliet P
    Ann N Y Acad Sci; 2002 Dec; 979():80-93. PubMed ID: 12543719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.